All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Performance comparison

Sermorelin vs Tesamorelin

An educational, source-based comparison of Sermorelin and Tesamorelin — how each peptide works, what it's researched for, and what to know before going deeper.

Growth Hormone Axis
Sermorelin

Shorter-acting GHRH analog used in clinical GH research.

Mechanism

A synthetic 29-amino-acid analog representing the active fragment of endogenous GHRH. Stimulates the pituitary to release GH in a physiologic, pulsatile pattern. Previously FDA-approved (Geref) for pediatric GH deficiency diagnosis before discontinuation for commercial reasons.

Research areas
  • Adult GH deficiency
  • Pediatric short stature (historical)
  • Sleep quality and body composition in aging
Considerations
  • No longer commercially available as an FDA-approved drug; available via compounding.
  • Requires physician oversight.
  • Banned in competitive sport.
Full Sermorelin profile →
Growth Hormone Axis
Tesamorelin

GHRH analog FDA-approved for HIV-associated visceral fat.

Mechanism

A stabilized analog of growth hormone-releasing hormone (GHRH) that stimulates pulsatile endogenous GH and IGF-1 release. FDA-approved (Egrifta) for the reduction of excess abdominal visceral fat in HIV-infected patients with lipodystrophy.

Research areas
  • Visceral adipose tissue reduction (approved)
  • Cognitive function in older adults (research)
  • NAFLD / hepatic fat (research)
Considerations
  • FDA-approved only for HIV-associated lipodystrophy.
  • May affect glucose tolerance; monitor in at-risk patients.
  • Requires physician oversight.
Full Tesamorelin profile →

Sermorelin vs Tesamorelin — Key differences

  • Class: Sermorelin is classified as Growth Hormone Axis, while Tesamorelin is Growth Hormone Axis.
  • Primary research focus: Sermorelinadult gh deficiency; Tesamorelinvisceral adipose tissue reduction (approved).
  • Tag: Growth hormone vs Body composition.

Related comparisons